Sora Tanjasiri and Marcelo Tolmasky posing with Gloria Castanon, CHERP scholar

Oct 27, 2023

Students Get Hands-On Opportunity in Cancer Disparities Research

A partnership with CSUF and UCI contributes to the enhancement of cancer health equity research in Orange County through the development of institutional capacities, support of meritorious joint cancer research pilot projects, and the provision of cancer research experiences and programs for underrepresented students.
Headshot of Krishnansu Tewari

Oct 25, 2023

Pre-Treatment Chemo Improves Cervical Cancer Survival Outcomes

Krishnansu S. Tewari, MD, professor and chief of the Division of Gynecologic Oncology in the Department of Obstetrics & Gynecology, comments on this new study that suggests survival odds improve when women receive so-called induction chemotherapy before their standard treatment regimen.
Sora Tanjasiri headshot

Oct 19, 2023

Breast Cancer Awareness Month with Cancer Prevention Researcher Dr. Sora Tanjasiri

In recognition of Breast Cancer Awareness month, cancer prevention researcher, Sora Park Tanjasiri, DrPH, professor of health, society, and behavior at the UCI Program in Public Health, answers common questions about breast cancer screening guidelines that are meant to reduce the risk of dying from this disease that 3.8 million women in the U.S. live with.

Sunmin Lee

Oct 17, 2023

Sleep and Chronic Diseases

Sunmin Lee: "Multimorbidity is a word used to describe the onset of more than one chronic condition occurring at the same time. An example of this would be if a person had both diabetes and cancer. In general, someone with this condition would live an overall lower quality of life considering healthcare providers would have to treat different conditions."

Headshot of Gelareh Sadigh

Oct 16, 2023

The Cost of Survival

Gelareh Sadigh, MD, associate professor in residence in the Department of Radiological Sciences, talks to the Radiological Society of North America about how cancer treatment expenses impact the patient's financial hardship, care and imagine adherence.
Headshot of Michael Demetriou

Oct 10, 2023

University of California, Irvine researchers awarded $2.4 million 'Fast Track' grant to develop a novel cancer immunotherapy treatment

The University of California, Irvine, has been awarded a $2.4 million ‘Fast Track’ Small Business Technology Transfer (STTR) grant from the National Cancer Institute (NCI) to further develop a highly novel cancer immunotherapy treatment. The project, a joint grant with GlyTR Therapeutics Inc, will build upon work at UCI originally funded by the President Biden Cancer Moonshot Program.
Headshot of Joel Milam

Oct 08, 2023

Childhood Cancer Survivors at High Risk of Lifelong Health Challenges, Study Finds

"Another issue for childhood cancer survivors is mental health, with depression rates of 2.3 to 40.8 percent, much higher than the national average of 9.6 percent. They had a greater suicide risk, especially those 28 and older. Adults who survived childhood cancer had a 1.4-fold higher suicide risk than the overall population."

Headshot of Roberto Tinoco

Sep 26, 2023

Unlocking the Potential of T Cells: A New Breakthrough in Chronic Infections and Cancer

Assistant Professor Roberto Tinoco and his UC Irvine research team have made a groundbreaking discovery regarding the vital role of a protein called High Mobility Group Box 2 (HMGB2), which was recently published in Nature Communications.
Headshots of Munjal Acharya and Alex Chan

Sep 19, 2023

UCI awarded $2.4 million grant to study potential treatment for cancer-related cognitive impairment

UCI has been awarded a five-year, $2.4 million grant from the National Cancer Institute to evaluate the augmentation of brain-derived neurotropic factor to alleviate cancer-related cognitive impairment. This multi-PI project translates findings from past human studies conducted by Alexandre Chan, Pharm.D., M.P.H., principal investigator and chair and professor of clinical pharmacy practice, into the laboratory, with the goal of evaluating the feasibility of enhancing the BDNF protein as a potential strategy for mitigating chemobrain. The study is being conducted in partnership with Munjal Acharya, M.S., Ph.D., associate professor of anatomy and neurobiology.
Headshot of Matthew Griffin

Sep 15, 2023

Professor Matthew Griffin Receives V Scholar for Cancer Research Award

Professor Matthew Griffin of the UC Irvine Department of Chemistry recently won the V Scholar for Cancer Research Award from the V Foundation — a charity founded in 1993 by ESPN and basketball coach Jim Valvano. This national award recognizes young tenure-track faculty who are early in their cancer research careers.